GSK to expand recall of antibiotics made at Worthing API unit

GSK campus in Worthing, UK

GSK will recall more antibiotics made at a UK API unit that has been offline since the US FDA raised contamination concerns last year.


US investor buys J&J's opiate API business and announces restructuring


Patheon will list on NYSE today

iStock/neil stanners

EMA proposes changes to Ph I guidelines after fatal BIA 10-2474 trial


Lonza: Biologic APIs boosted H1 revs and CAR-T deal will help sustain growth in H2


Johnson Matthey: Q1 API revenues down on order timings


Pharma AMAC supplies look more secure: New firm MCM to buy Ineos' Barex resin IP

See More Headlines

Regulatory & Safety

Sandoz' Bioinject facility in Austria. One of several sites that could make biosimilar pegfilgrastim for the US

US FDA rejects Sandoz’s Neulasta biosimilar

(Image: iStock/DenKuvaiev)

Report: Congress needs to update human research regulations


Constipation med linked to 46 B. cepacia cases in US recalled by PharmaTech

See More in Regulatory & Safety


US calls for simplified API and chem sector oversite in China to stem flow of meth precursors (iStock/kaarsten)

China's complex API regs fuelling US meth problem says congressional committee

FDA adds 4 API manufacturers to 'Red List'

FDA adds 4 API manufacturers to 'Red List'


MilliporeSigma has signed an excipient distribution deal with PCAS

See More in Ingredients

Drug Delivery


Evonik to buy CDMO for drug delivery technologies


MonoSol Rx licenses film tech to Kuraray-owned namesake for non-pharma uses

Ravikumar Majeti, Ph.D. is a professor of pharmaceutical sciences at the Texas A&M Irma Lerma Rangel College of Pharmacy, and his team at work in his lab. (Image: Texas A&M Health Science Center)

Pharmacy researchers work to improve drug delivery

See More in Drug Delivery


iStock/Marcio Silva

World bank will loan B. Braun $33m for Indonesia injectables plant


GE Healthcare eyeing more cell and gene therapy production tech supplier takeovers

Image: iStock/jarun011

Advaxis: Manufacturing, safety and efficiency key to developing cancer drugs

See More in Processing

Popular News

FDA adds 4 API manufacturers to 'Red List'

FDA adds 4 API manufacturers to 'Red List'

EMA HQ in Canary Warf London (iStock/GordonBellPhotography)

EMA reviewing several drugs made by Pii in light of MHRA inspection

(Image: iStock/VladimirFLoyd)

APIs: high-volume business with low profit margins, says analyst




Latest Products

See more products